OR WAIT null SECS
June 29, 2022
As director of corporate strategy for Novartis, Kamenska defines direction for the company’s overall enterprise. Here, she discusses how the pandemic and recent market events are shaping these strategies.
Employees must be able to retain information and remain engaged to keep pace with highly regulated industry.
June 17, 2022
We may be only at the beginning of outcome-measured, value-based healthcare, but this is a chance for pharma organizations to show their mettle as roles are redefined and definitions of ‘value’ are agreed, says Gérard Klop of Vintura.
Automated risk management and improved regulatory compliance among opportunities offered by case collection.
June 16, 2022
Recent increases in employee burnout and turnover must be addressed.
June 03, 2022
COVID-19 pandemic has accelerated raised expectations for medical information professionals.
June 02, 2022
Moorman discusses critical aspects of key account management in pharma.
May 25, 2022
Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
May 24, 2022
Pandemic workforce trends continue to create challenges for pharma.
Improvements in R&D, manufacturing, and data sharing will extend platform’s reach.
